The Lancet Oncology in conversation with
195 episodes - English - Latest episode: about 2 months ago - ★★★★★ - 1 ratingEditors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from early-stage breast cancer treatment to mRNA vaccines, the access to essential cancer medicines for children to measuring ovarian toxicity, and more.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
The Lancet Oncology: September 30, 2011
September 30, 2011 07:00 - 12 minutes - 8.8 MBOctober highlights, including discussion of the trial about the tyrosine kinase ALK and non-small-cell lung cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: September 26, 2011
September 26, 2011 07:00 - 51 minutes - 35.5 MBDavid Collingridge launches The Lancet Oncology Commission on delivering affordable cancer care in high-income countries. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: August 26, 2011
August 26, 2011 07:00 - 9 minutes - 6.9 MBSeptember issue highlights, including discussion of HPV testing and cytology. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: July 29, 2011
July 29, 2011 07:00 - 10 minutes - 7.57 MBThe role of dignity therapy in end-of-life cancer care. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: June 24, 2011
June 24, 2011 07:00 - 11 minutes - 8.03 MBEmma Grainger with July highlights, and an interview about a trial assessing the value of zoledronic acid in the treatment of pre-menopausal early breast cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: May 27, 2011
May 27, 2011 07:00 - 7 minutes - 5.09 MBJune issue highlights, including faecal blood tests to assess future colorectal cancer risk, and of the 'dangerous liaison' between cancer and tuberculosis. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: April 29, 2011
April 29, 2011 07:00 - 8 minutes - 5.98 MBMay highlights, including discussion of a phase II study about the treatment of B-cell lymphoma in very old patients. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: April 01, 2011
April 01, 2011 07:00 - 18 minutes - 12.7 MBApril issue highlights, including the latest developments of the breast Health Global Initiative(BHGI), including an interview with BHGI Director Benjamin Anderson. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: March 01, 2011
March 01, 2011 08:00 - 9 minutes - 6.65 MBMarch issue highlights, including new data from the HERA trial about long-term efficacy of herceptin for early breast cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: January 31, 2011
January 31, 2011 08:00 - 5 minutes - 3.63 MBRob Brierley with February highlights, including the prevalence of depression among cancer patients. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: December 30, 2010
December 30, 2010 08:00 - 9 minutes - 6.69 MBJanuary highlights, including automated verses manual cytology for detection of cervical cancers. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: November 29, 2010
November 29, 2010 08:00 - 8 minutes - 5.69 MBDecember issue highlights, including mammography screening for younger women with familial breast cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: November 01, 2010
November 01, 2010 07:00 - 4 minutes - 2.82 MBNovember issue highlights, including an large-scale HPV genotype analysis with implications for cervical-cancer vaccine development, and the potential for discontinuation of imatinib treatment for people with chronic myeloid leukaemia. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://yo...
The Lancet Oncology: October 04, 2010
October 04, 2010 07:00 - 14 minutes - 9.91 MBIncludes author interview about a trial comparing sentinal-lymph-node biopsy with axillary-lymph-node dissection in breast cancer treatment. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: September 01, 2010
September 01, 2010 07:00 - 5 minutes - 3.64 MBSeptember issue highlights, including discussion of a possible association between hepatitis B infection and non-Hodgkin lymphoma in a Korean population. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: August 02, 2010
August 02, 2010 07:00 - 7 minutes - 5.45 MBAugust issue highlights, including bevacizumab for NSCLC, and cancer issues among people with mental illness. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: July 05, 2010
July 05, 2010 23:00 - 10 minutes - 6.99 MBRoy Herbst discusses the Zodiac trial, a phase 3 study assessing the efficacy of vandetanib for treating advanced non-small-cell lung cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: June 01, 2010
June 01, 2010 07:00 - 11 minutes - 7.92 MBEmma Grainger discusses erlotinib as maintenance treatment for lung cancer, and IGF1 and risk of breast cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: April 29, 2010
April 29, 2010 07:00 - 12 minutes - 8.42 MBThe role of zoledronic acid with chemotherapy for early breast cancer and other issue highlights are discussed. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: March 29, 2010
March 29, 2010 07:00 - 7 minutes - 4.88 MBApril issue highlights, including a genome-wide association study of lung cancer for never smokers. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: March 01, 2010
March 01, 2010 08:00 - 4 minutes - 3.43 MBMarch issue highlights, including hypofractionated radiotherapy for early breast cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: February 01, 2010
February 01, 2010 08:00 - 7 minutes - 5.17 MBDiscussion of phase I novel targeted therapy for sarcoma. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: January 06, 2010
January 06, 2010 08:00 - 16 minutes - 11.2 MBEmma Grainger with issue highlights and Kathy Albain discussing chemotherapy and tamoxifen for post-menopausal women with breast cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: December 01, 2009
December 01, 2009 08:00 - 8 minutes - 5.8 MBAudrey Ceschia discusses issue highlights, including impact of HIV infection on cancer risk. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: October 29, 2009
October 29, 2009 07:00 - 30 minutes - 18 MBDiscussion of new oncology management guidelines derived from didactic workshops at the Asia Oncology Summit 2009. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: September 28, 2009
September 28, 2009 07:00 - 5 minutes - 3.79 MBRob Brierley discusses an antithrombolic agent for patients receiving chemotherapy for solid tumours. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: August 27, 2009
August 27, 2009 07:00 - 12 minutes - 8.79 MBDiscussion of prostate cancer treatment, the PASSION-P trial, and a new Quackery column. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: July 29, 2009
July 29, 2009 07:00 - 5 minutes - 4.01 MBRob Brierley discusses sunitinib for kidney cancer, and how bureaucracy is stifling UK clinical research. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: July 01, 2009
July 01, 2009 07:00 - 11 minutes - 7.98 MBEmma Grainger discusses bariatric surgery, weight loss, and cancer risk for obese people. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: May 28, 2009
May 28, 2009 07:00 - 10 minutes - 7.37 MBAudrey Ceschia discusses issue highlights, including treatment for nausea and vomiting from chemotherapy. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: April 29, 2009
April 29, 2009 07:00 - 10 minutes - 6.92 MBDavid Collingridge discusses research articles on prophylactic cranial irradiation for small-cell lung cancer, and the addition of temozolomide to radiotherapy for treating glioblastoma. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: March 30, 2009
March 30, 2009 07:00 - 6 minutes - 4.5 MBRob Brierley discusses research articles on cancer survival in England, and the potential for ovarian cancer screening. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: March 05, 2009
March 05, 2009 08:00 - 13 minutes - 9.27 MBEmma Grainger discusses articles on myelodysplastic syndromes, circulating tumour cells and prostate cancer, and palliative stents for oesophageal cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: January 30, 2009
January 30, 2009 08:00 - 5 minutes - 4.09 MBRob Brierley discusses two research articles investigating genetic subtypes of childhood acute lymphoblastic leukaemia. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: December 23, 2008
December 23, 2008 08:00 - 12 minutes - 8.75 MBEmma Grainger discusses liver transplantation criteria, sorafenib for liver cancer in the Asia-Pacific, and NICE guidance on erlotinib for non-small-cell lung cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: November 26, 2008
November 26, 2008 08:00 - 9 minutes - 6.65 MBDavid Collingridge discusses a research article comparing microsurgery with total excision for basal-cell carcinoma of the face, and other content highlights. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: October 28, 2008
October 28, 2008 07:00 - 5 minutes - 3.82 MBRob Brierley introduces the latest issue, including research articles about prostate cancer and a review highlighting the importance of appropriate palliative care. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: October 01, 2008
October 01, 2008 07:00 - 16 minutes - 11.4 MBJohn Sellors and Guglielmo Ronco discuss HPV screening for precursors of cervical cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: August 26, 2008
August 26, 2008 07:00 - 8 minutes - 5.99 MBSally van der Meer discusses highlights from the September journal in this issue's podcast, including a new treatment option for preventing bone mineral loss among pre-menopausal women receiving hormone therapy for early breast cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://yo...
The Lancet Oncology: August 11, 2008
August 11, 2008 07:00 - 11 minutes - 7.93 MBThe Lancet Oncology podcast - a global health theme for the August issue. Editor David Collingridge discusses the highlights, including cancer survival from five continents, and a review of cancer issues in Africa. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Oncology: June 30, 2008
June 30, 2008 07:00 - 8 minutes - 6.18 MBTLO Editor David Collingridge discusses some highlights from the July issue: radiofrequency ablation showing promise for the treatment of lung cancer; how a rare form of obesity could negatively affect treatment outcomes; and a discussion of a recent meeting at IARC in Lyon, France, concerning the latest evidence on smoke-free policies and the effects on public health. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOn...
The Lancet Oncology: June 09, 2008
June 09, 2008 07:00 - 13 minutes - 9.3 MBEmma Cannell and Sally van der Meer discuss highlights from the June issue: a prospective pilot study assessing the role of stellate-ganglion block to treat hot flushes in survivors of breast cancer; also discussed is a Personal View about cancer of unknown primary (CUP), and the Leading Edge on public confidence in Merck's HPV vaccine. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelanc...
The Lancet Oncology: April 30, 2008
April 30, 2008 07:00 - 12 minutes - 8.85 MBEditor David Collingridge discusses highlights from the May issue: the natural history of cervical intraepithelial neoplasia; the effect of screening on prostate-cancer mortality in the USA and UK; and the launch of a series of reviews about cancer in indigenous populations, starting this month with cancer among indigenous Polynesians. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelance...
The Lancet Oncology: March 26, 2008
March 26, 2008 07:00 - 12 minutes - 8.56 MBEditor David Collingridge discusses highlights from the April issue including: encouraging results from the START trials suggest fewer fractions of radiotherapy could revolutionise treatment of early stage breast cancer; how a phase II study investigating yttrium-90 labelled ibritumomab could have an important future role in the treatment of follicular non-Hodgkin lymphoma, and finally the pressing need for increased recruitment of adolescents and young adults in to cancer trials. Continue ...
The Lancet Oncology: February 25, 2008
February 25, 2008 08:00 - 12 minutes - 8.88 MBDr David Collingridge, Editor of the Lancet Oncology, discusses highlights of the March issue in the first Lancet Oncology podcast. Two main topics are discussed: a research article highlighting how individuals in the United States who are under-insured or who have no medical insurance are at an increased risk of presenting with late-stage cancers; non-whites are at a similarly increased cancer risk. Also featured is a Dutch study showing the potential benefits of a shared-care programme bet...